Stock IRLAB A IRLAB THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Charts IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Delayed Nasdaq Stockholm
Other stock markets
 06:59:54 2024-04-30 am EDT 		5-day change 1st Jan Change
11.4 SEK +1.33% Intraday chart for IRLAB Therapeutics AB -0.87% +52.00%
Mar. 22 IRLAB Therapeutics Receives Minutes from End-of-Phase 2 Meeting Confirming Alignment with the FDA on the Phase III Program for Mesdopetam CI
Mar. 19 IRLAB Therapeutics AB Mesdopetam Displays Antipsychotic Properties in an Advanced Model of Parkinson's Disease Psychosis CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Neutral

Neutral

Resistance 13.80 19.60 18.80
Spread/Res.-17.39%-41.84%-39.36%
Spread/Supp.+11.22%+93.22%+83.87%
Support 10.25 5.900 6.200

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. IRLAB A Stock
  4. Charts IRLAB Therapeutics AB